Novo CEO says pills could capture 50% of weight-loss market by 2030

Weight-loss pills could capture as much as ​half of the global obesity drug market by 2030, Novo Nordisk's chief ‌executive told Reuters on Tuesday, as the Danish drugmaker positions itself for a shif...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。